Year: 2023

Medical Aesthetics Market Size, Share & Growth Analysis, [2029] | With CAGR of 12.2%

Written by Customer Service on December 13, 2023. Posted in Mergers And Acquisitions.

At 12.2% CAGR, the global Medical Aesthetics Market size is projected to reach USD 45.91 billion by 2029Medical Aesthetics MarketMedical Aesthetics Market (2022-2029)Pune, India, Dec. 13, 2023 (GLOBE NEWSWIRE) — The global medical aesthetics market size was valued at USD 20.54 billion in 2022 and it is projected to reach USD 45.91 billion by 2029, exhibiting a CAGR of 12.2% during the forecast period. The increasing adoption of non-surgical treatment options is due to the various benefits such as lower side effects, less recovery time, and faster results. Fortune Business Insights, presents this information in its report titled, “Medical Aesthetics Market 2022-2029.”Request a Free Sample PDF – https://www.fortunebusinessinsights.com/enquiry/sample/medical-aesthetics-market-100631Medical Aesthetics Market Key...

With 11.8% CAGR, Cell Culture Media Market Size to surpass USD 5.60 Billion by 2030

Written by Customer Service on December 13, 2023. Posted in Mergers And Acquisitions.

According to a Fortune Business Insights research, the size of the global cell culture media market is expected to grow at a compound annual growth rate (CAGR) of 11.8%, reaching a projected value of USD 5.60 billion by 2030.Cell Culture Media MarketCell Culture Media Market (2023-2030)Pune, India, Dec. 13, 2023 (GLOBE NEWSWIRE) — The global cell culture media market size was valued at USD 2.43 billion in 2022, and it is anticipated to surge from USD 2.56 billion in 2023 to USD 5.60 billion by 2030, exhibiting a CAGR of 11.8% over the study period. The expansion is driven by an increase in expenditure by pharmaceutical companies for conducting R&D initiatives. Fortune Business Insights™ provides this information in its research report, titled “Cell Culture Media Market, 2023-2030”.Key Industry Development: June...

With 4.4% CAGR, Airway Management Devices Market Size, Share & Growth Analysis, [2030]

Written by Customer Service on December 13, 2023. Posted in Mergers And Acquisitions.

As per the report by Fortune Business Insights, The global airway management devices market size was valued at USD 1.81 billion in 2021 and is projected to reach a valuation of USD 1.89 billion in 2022. The market is expected to reach USD 2.55 billion by 2029 with a CAGR of 4.4% during the forecast period.Airway Management Devices MarketForecast 2022-2029Pune, India, Dec. 13, 2023 (GLOBE NEWSWIRE) — Global airway management devices market size was valued at USD 1.81 billion in 2021 and The market is expected to reach USD 2.55 billion by 2029 with CAGR of 4.4% during forecast period. Decline in the Conduction of Elective Surgeries During Pandemic Led to Drop in the Market Progress. Changes in lifestyle, physical inactivity, poor nutrition, and habitual factors such as tobacco and excessive alcohol use have given rise to...

Scorpio Tankers Inc. Announces Updates on Fourth Quarter 2023 Daily TCE Revenues and Debt and Lease Activity

Written by Customer Service on December 13, 2023. Posted in Earnings Releases And Operating Results.

MONACO, Dec. 13, 2023 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE:STNG) (“Scorpio Tankers,” or the “Company”) announces updates on fourth quarter of 2023 Daily TCE Revenues and recent debt and lease activity. Fourth Quarter of 2023 Daily Time Charter Equivalent (“TCE”) Revenues Below is a summary of the estimated average daily Time Charter Equivalent (“TCE”) revenue and duration of contracted voyages and time charters for the Company’s vessels (both in the pools and outside of the pools) thus far in the fourth quarter of 2023 as of the date hereof: Pool and Spot Market Time Charters Out of the PoolVessel class Average DailyTCE Revenue (1) ExpectedRevenue Days (2) % of Days Average DailyTCE Revenue (1) ExpectedRevenue Days (2) % of DaysLR2 $ 38,000 2,550 92 % $ 30,750 910 100 %MR $ 32,500 4,850 87 % $ 21,800 450 100 %Handymax $ 30,000 1,250 84 % N/A N/A N/A (1) TCE...

Photronics Reports Full Year and Fourth Quarter Fiscal 2023 Results

Written by Customer Service on December 13, 2023. Posted in Earnings Releases And Operating Results.

BROOKFIELD, Conn., Dec. 13, 2023 (GLOBE NEWSWIRE) — Photronics, Inc. (NASDAQ:PLAB), a worldwide leader in photomask technologies and solutions, today reported financial results for its full year and fourth quarter of fiscal year 2023 ended October 31, 2023. “We delivered our sixth consecutive year of record revenue with growth in fourth quarter amidst a prolonged industry downturn,” said Frank Lee, chief executive officer. “Fourth quarter and full year revenue increased 8% year-over-year, and fourth quarter increased 1% sequentially. Both IC and FPD increased, as demand for our design-driven products remained strong. Operating expenses were lower sequentially, partially offsetting lower gross profit, resulting in operating margins of 28.5% for the fourth quarter and 28.4% for the year. Strong cash generation and our disciplined...

Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM

Written by Customer Service on December 13, 2023. Posted in Public Companies.

Initial results show promising clinical activity in heavily pretreated patients 22 patients evaluable for efficacy: 3 patients on therapy longer than 10 months, 1 patient longer than 6 months, and 5 patients longer than 4 months 19 patients with measurable disease by RANO criteria: 1 patient with confirmed partial response and 8 patients with stable disease BDTX-1535 generally well tolerated, consistent with prior disclosures and no new safety signals observed “Window of opportunity” trial enrolling patients to assess PK in brain tissue CAMBRIDGE, Mass., Dec. 13, 2023 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with genetically defined cancers, today announced topline results from the...

Kymera Therapeutics to Host Virtual Immunology R&D Day on January 4

Written by Customer Service on December 13, 2023. Posted in Public Companies.

Company to provide update on its emerging pipeline of high-value immunology programs WATERTOWN, Mass., Dec. 13, 2023 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today shared webcast information for the virtual Immunology R&D Day that the Company will host on January 4, 2024, from 10:00 a.m. to 12:00 p.m. ET. The R&D Day will focus on the Company’s emerging pipeline of high-value immunology programs, including new target disclosures, supporting preclinical data and timing to clinical study initiation. To join the webcast, please visit this link, or the “Events and Presentations” page of the Investors section on the Company’s website at www.kymeratx.com. A replay of the...

Epazz Holdings: ZenaDrone Was Awarded Phase 1 US Air Force SBIR Dual-Purpose Technology Contract

Written by Customer Service on December 13, 2023. Posted in Public Companies.

Epazz, Inc.Epazz CEO Shaun Passley, Ph.D. meets with the US Ambassador for the United Arab Emirates Martina Strong and Space Shuttle Pilot Commander Col. Mike Bloomfield at the Dubai Air Show on 13-17 November 2023CHICAGO, IL, Dec. 13, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — Epazz, Inc. (OTC: EPAZ), a mission-critical provider of drone technology, blockchain mobile apps and cloud-based business software solutions, announced today one of its holdings, ZenaDrone, Inc., was selected and funded for the US Air Force Small Business Innovation Research (SBIR) Award for phase I of the innovative defense-related dual-purpose technology. The company is working with an assigned US Air Force contract agent to complete the paperwork and begin the contract over the next year. ZenaDrone has 90 days to complete the contract to...

Elevate Everyday Wellness Rituals With Solei Cannabis Teas

Written by Customer Service on December 13, 2023. Posted in Public Companies.

Solei Introduces Three New Seasonal Brews for Tea Lovers TORONTO, Dec. 13, 2023 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today announces the latest seasonal release from its cannabis wellness brand, Solei. Joining its list of elevation essentials, Solei introduces three new cannabis-infused tea blends, including Decaffeinated Jasmine Green Tea, Spiced Starlight, and Chai Rooibos that are now available, just in time for the cozy season ahead. Earlier this Spring, Solei introduced its inaugural tea collection with the launch of Peach Ginger Green Tea, Lavender Chamomile, and Mint Tea, focused on intentional consumption around its cannabinoid variations of CBD, CBN, and THC. Now back with three additional...

ABM Reports Fourth Quarter and Full Year Fiscal 2023 Results and Provides Fiscal 2024 Outlook

Written by Customer Service on December 13, 2023. Posted in Earnings Releases And Operating Results.

Grew fourth quarter revenue 4.1% to $2.1 billion, including 3.8% organic growth Fourth quarter net income of $62.8 million and GAAP EPS of $0.96, up 29% and 32%, respectively Fourth quarter adjusted EBITDA of $144.2 million, up 10% Fourth quarter adjusted EPS of $1.01, up 13% Board of Directors approves a $150 million expansion of existing share repurchase authorization Fiscal 2024 adjusted earnings per share expected to be in range of $3.20 to $3.40 (1)NEW YORK, Dec. 13, 2023 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility solutions, today announced financial results for the fourth quarter and full year ended October 31, 2023. “Our team executed well in the fourth quarter, delivering 4.1% revenue growth and strong margins, resulting in double-digit growth in net income, adjusted EBITDA and adjusted EPS....

Year: 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals